Warren James Huff Net Worth & Insider Trades

Warren James Huff - Chief Executive Officer, Reata Pharmaceuticals Inc

As of January 6, 2021

What is Warren James Huff's Net Worth?

The current estimated net worth of Reata Pharmaceuticals Inc's Chief Executive Officer, Warren James Huff, is estimated to be about $19.79M . Warren James Huff owns about 1,583 units of Reata Pharmaceuticals Inc common stock. In the last 5 years at Reata Pharmaceuticals Inc, Warren James Huff has sold an estimated value of $19.75M worth.

What is Warren James Huff's Past Insider Trading?

Warren James Huff's largest purchase order was 179,823 units , worth over $1.25M on June 2, 2016. Warren James Huff's largest sale order was 81,657 units , worth over $14.29M on November 10, 2020. In total, Warren James Huff has made about 11 transactions over 5 years of their time at Reata Pharmaceuticals Inc. Warren James Huff usually trades in January and December, with the busiest year in 2019 and 2016.

Warren James Huff

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Warren James Huff's Salary in 2020?

As Chief Executive Officer of Reata Pharmaceuticals Inc, Warren James Huff has a total base salary of $636,400 . Warren James Huff received compensation valued at about $6,396,130 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of a bonus of $413,660 , other earnings, plans or compensations of $5,000 , and other earnings, plans or compensations of $5,000 .

What is Warren James Huff's' Mailing Address?

  • Mailing address is C/o Reata Pharmaceuticals, Inc. 2801 Gateway Dr. Suite 150 Irving TX 75063 TX

Reata Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
J. Warren Huff 2020 $636,400 $413,660 - $5,000 $5,000 $6,396,130
J. Warren Huff 2019 $578,500 $600,540 - $16,715 $16,715 $5,542,605
J. Warren Huff 2018 $534,000 $400,500 - - - $934,500
Manmeet S. Soni 2020 $545,900 $445,700 - $136,125 $136,125 $4,465,894
Manmeet S. Soni 2019 $179,385 $408,873 - $70,243 $70,243 $12,261,587
Dawn C. Bir 2020 $422,000 $239,900 - $5,000 $5,000 $3,871,542
Dawn C. Bir 2019 $375,100 $287,550 - $3,500 $3,500 $1,975,899
Colin J. Meyer, M.D. 2020 $513,951 $381,400 - - - $4,233,520
Colin J. Meyer, M.D. 2019 $445,600 $389,467 - - - $2,182,780
Colin J. Meyer, M.D. 2018 $417,000 $208,500 - - - $625,500
Michael D. Wortley 2020 $421,100 $339,500 - - - $3,965,242
Michael D. Wortley 2019 $382,800 $341,400 - - - $2,033,949
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1358762/000156459021022192/reta-def14a_20210610.htm

What are Reata Pharmaceuticals Inc's Past Insider Trades?

Reata Pharmaceuticals Inc's most recent insider trade came on January 4, 2022 by Singh Manmeet Soni who bought 16,000 units worth $419.56K . In the last 5 years, insiders at Reata Pharmaceuticals Inc have sold an estimated value of $113.89M and bought an estimated value of $138.22M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Douglas Jason Wilson, Executive VP Operations,  Elaine Castellanos, VP,  and R. Kent McGaughy Jr., Director .

REATA PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1